Webinar Labeling and Induced Infringement in Pharma Patent Litigation and Protecting IP Rights October 12, 2023 1:00 PM - 2:30 PM Virtual
Speaking Engagement LSPN Chairman's Opening Address and Closing Remarks October 10, 2023 - October 11, 2023 San Francisco, CA
Press Release LMG Life Sciences Ranks Sterne Kessler and Seven Directors for Patent Litigation and Prosecution Sterne, Kessler, Goldstein & Fox September 21, 2023
Podcast Recording & Transcript Meat & Potatoes Episode 224: Paul A. Ainsworth, Sterne Kessler September 13, 2023
Press Release Sterne Kessler Presented With Two Top Honors at 2023 LMG Life Sciences Americas Awards Sterne, Kessler, Goldstein & Fox September 8, 2023
Speaking Engagement Preparing for Biosimilar Carve Outs: Will Skinny Labelling Work for Biosimilars? June 27, 2023 4:15 PM - 5:15 PM Boston, MA
Press Release Firm and 18 Sterne Kessler Directors Earn Top Rankings in 2023 IAM Patent 1000 for World-Class Patent Work Sterne, Kessler, Goldstein & Fox June 26, 2023
In the News Sterne Kessler Team Scores Federal Circuit Win for Teva in Sleep Disorder Drug Litigation Law360 May 10, 2023
In the News Sterne Kessler Represents Teva in Sleep Disorder Drug Win at Federal Circuit Bloomberg Law May 10, 2023
Bylined Articles Introduction – Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2022 Decisions Sterne, Kessler, Goldstein & Fox February 6, 2023 Michael Joffre, Ph.D.
Bylined Articles Nippon Shinyaku Co. v. Sarepta Therapeutics, Inc., 25 F.4th 998 (Fed. Cir. 2022) (Newman, Lourie, Stoll) Sterne, Kessler, Goldstein & Fox February 6, 2023 William H. Milliken
Bylined Articles Watching the Pot™ Sterne, Kessler, Goldstein & Fox January 30, 2023 Deborah Sterling, Ph.D.
In the News Second Wave of Biosimilar Cases Sharpens Patent Counsel Focus Managing IP January 27, 2023
In the News The Three Developments Exciting US Patent Practitioners in 2023 Managing IP January 6, 2023